Does Vascepa Interact with ACE Inhibitors?
Vascepa (icosapent ethyl), a purified EPA omega-3 for reducing cardiovascular risk, shows no major drug interactions with ACE inhibitors like lisinopril or enalapril in standard databases. No clinical trials or post-marketing data report increased side effects from this combination. Vascepa primarily affects triglycerides and does not significantly alter CYP450 enzymes or renal function pathways that ACE inhibitors target.[1][2]
Common Side Effects of Each Alone
Vascepa's main side effects are mild: gout (1.7% vs 1.1% placebo), atrial fibrillation (5% vs 3.9%), and joint pain. Bleeding risk is low without antiplatelets.[1]
ACE inhibitors commonly cause dry cough (up to 20%), hyperkalemia, dizziness, and angioedema (rare). They can raise creatinine slightly via efferent arteriole dilation.[3]
Potential Risks When Combined
No evidence of amplified side effects like heightened bleeding, hypotension, or renal issues. Vascepa's minimal antiplatelet effect doesn't worsen ACE inhibitor-related cough or potassium shifts. A small pharmacokinetic study found no change in ACE inhibitor levels with omega-3s.[2][4] Monitor blood pressure and potassium routinely, as with any CV regimen.
What Studies Say
The REDUCE-IT trial (8,179 patients) tested Vascepa with standard therapies, including ACE inhibitors (used by ~50% of participants), and reported no interaction signals for adverse events.[1] Real-world data from FDA FAERS echoes this, with no clustered reports of worsened outcomes.[5]
Patient Tips and Monitoring
Start with standard doses. Watch for gout flares if prone, as both can mildly elevate uric acid. Consult a doctor for personalized checks, especially with kidney issues. No dose adjustments needed per prescribing info.[1][3]
[1]: Vascepa Prescribing Information
[2]: Drugs.com Interaction Checker - Vascepa + Lisinopril
[3]: ACE Inhibitors Overview - UpToDate
[4]: Lexicomp Drug Interactions (2023)
[5]: FDA FAERS Public Dashboard